COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Governor Daniel Pruce said Thursday that his current term as Governor of the Virgin Islands is expected to conclude in January 2027, though discussions regarding possible flexibility or an extension remain ongoing.

Mr. Pruce made the comments during a May 7 press conference at Government House after being asked by members of the media about the length of his tenure and whether he would consider remaining in the role beyond the standard term.

“My tenure would normally be for a period of three years,” Mr. Pruce said. “So that would be until January of 2027.”

The governor said conversations are taking place regarding possible adjustments to that timeline but noted that no final decision has been made.

“I am in the midst of looking at what options there may be in terms of flexibility around that timing,” he said. “It would be premature of me to go into any detail now.”

Mr. Pruce, who was sworn in as governor in January 2024, said any decision regarding an extension would not rest solely with him.

“But obviously, if given the opportunity to remain in the Virgin Islands for any longer, I’d be absolutely delighted,” he said. “This is a decision that sits beyond my particular responsibilities.”

During the press conference, Mr. Pruce also addressed a range of issues under his portfolio, including law enforcement reform, the appointment process for the next Commissioner of Police and ongoing security initiatives across the territory.

Governor Daniel Pruce announced Thursday that the vetting process for officers within the Royal Virgin Islands Police Force has officially begun following the completion of data-sharing agreements between government agencies and the vetting unit.

Speaking during a May 7 press conference at Government House, Mr. Pruce said the agreements were a critical step in advancing reforms aimed at strengthening integrity and accountability within the police force.

“The data-sharing agreements between the relevant local government agencies and the vetting unit have now been finalized,” Mr. Pruce said. “With those documents in place, the vetting process is now underway.”

Mr. Pruce described the start of the process as a significant milestone for law enforcement reform in the Virgin Islands. He said the vetting initiative is intended to strengthen public confidence in the police force, protect national security and ensure the integrity of officers serving within the organization.

“As we’ve discussed previously in these briefings, vetting is a vital measure,” he said. “It’s an essential measure to ensure the integrity of the RVIPF, to strengthen public confidence while also preserving the safety of officers and ensuring national security.”

The governor has previously identified the development of a fully vetted and professionally resourced police force as one of his main security priorities since taking office in January 2024.

During the press conference, Mr. Pruce also said the United Kingdom continues to provide support to the territory’s security agencies, including funding positions within the police force and deploying experienced prison officers to assist at HM Prison Balsam Ghut.

The vetting process forms part of broader law enforcement reforms introduced following recommendations from the Commission of Inquiry and ongoing security assessments within the territory.